Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection.

Eitemau Tebyg

• Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
  gan: Cornelissen, B, et al.
  Cyhoeddwyd: (2006)
• Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
  gan: Cornelissen, B, et al.
  Cyhoeddwyd: (2007)
• Kinetics of internalization and nuclear import and efflux of 111In-and 123I-labeled HIV-1 tat-peptide immunoconjugates (IC's) in BT-474 human breast cancer cells
  gan: Cornelissen, B, et al.
  Cyhoeddwyd: (2006)
• Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.
  gan: McLarty, K, et al.
  Cyhoeddwyd: (2009)
• 111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
  gan: Cornelissen, B, et al.
  Cyhoeddwyd: (2009)